欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7649/001
药品名称Ligobesy
活性成分
    • liraglutide 6.0 mg/ml
剂型Solution for injection in pre-filled pen
上市许可持有人Sun Pharmaceutical Industries (Europe) B.V. Polarisavenue 87 2132 JH Hoofddorp Netherlands
参考成员国 - 产品名称Germany (DE)
Ligobesy 6 mg/ml Injektionslösung im Fertigpen
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
      Byesilor 6 mg/ml oplossing voor injectie in een voorgevulde pen
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Ligobesy
许可日期2024/10/22
最近更新日期2025/01/09
药物ATC编码
    • A10BJ02 liraglutide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase